Recombinant Human GADD45G (N-6His)

Description

EnkiLife provides the Recombinant Human GADD45G (N-6His) protein,aslo know as Growth Arrest and DNA Damage-Inducible Protein GADD45 Gamma,Cytokine-Responsive Protein CR6,DNA Damage-Inducible Transcript 2 Protein,DDIT-2,GADD45G,CR6,DDIT2, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Growth Arrest And DNA Damage-Inducible Protein GADD45 Gamma is produced by our E.coli expression system and the target gene encoding Met1-Glu159 is expressed with a 6His tag at the N-terminus.Accession:O95257. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:19.28 KDa. Background:Growth Arrest and DNA Damage-Inducible Protein GADD45 Υ (GADD45G) is a nuclear protein which belongs to the GADD45 family. GADD45G is highly expressed in placenta. GADD45G interacts with various proteins whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. GADD45G responds to environmental stresses by mediating activation of the p38/JNK pathway via MTK1/MEKK4 kinase. GADD45G is also involved in the regulation of growth and apoptosis. GADD45G inhibits cell growth and differentiation by androgens. The mRNA expression is down-regulated in hepatocellular carcinoma.